International Conference on "eLearning for Human Capability Development" to Commence Tomorrow    Deputy Finance Minister for International Affairs Participates in Finance Deputies in Arab Countries 7th Meeting    Advanced Electronics Company to Participate in IKTVA 2022 Forum and Exhibition    Ministry of Health Reports 4,535 New COVID-19 Cases, 5,072 Recoveries in Saudi Arabia    Magnitude 5.8 Earthquake Strikes Chinese Province of Qinghai    Egypt Records 1569 New Cases of COVID-19    Weather Forecast for Sunday    Custodian of the Two Holy Mosques Condoles Brazilian President on Death of his Mother    New Zealand to Impose Restrictions After Omicron Community Spread    French President Makes Phone Call to Tunisian Counterpart    Saudi Handball Team Loses to Qatar in Main Round of 2022 Asian Men's Handball Championship    Al-Zamil: Forum represents great importance in enhancing KSA's industrial position    UAE stops drone flying operations    From Milan to Glasgow, young Moroccans commit to fighting climate change    Kingdom chairs meeting of aviation security experts group    Eighth Season of ABB FIA Formula E World Championship to kick off in Diriyah    Bocelli performs in AlUla in third Winter at Tantora    Women's presence in Saudi cybersecurity sector reaches 45%    RCU launches first autonomous electric pod in AlUla    Recoveries keep pace with new COVID-19 cases in KSA as numbers stay below 5,000–mark    Pope Francis pledges justice for abuse victims after report faults Benedict XVI    Saudi Arabia arrests 13,780 illegals in a week    3.5 million students return to in-person classes on Sunday    700 women footballers vie for a place in first-ever national team Jeddah hosts Green Ladies' first training camp    Six-time champion Al-Attiyah heads impressive field for Oman Rally Czech duo of Petr Kačirek and Václav Kopáček make first Oman appearance    Brazil to stop unvaccinated footballers playing in top leagues    Al-Jadaan: Flexible and measured approach in green, sustainable global economy is required    Houthi' allegations of Coalition targeted a detention center in Saada is incorrect: Brig. Gen. Al-Maliki The media reports marketed by Houthi militia reflects its usual misleading approach    20th Asian Handball Championship Main Round to Kick off Tomorrow    Yanbu Education wins two awards for distinguished academic performance in GCC    Tearful Adele postpones entire Las Vegas residency    'Bat Out Of Hell' singer Meat Loaf dies at 74    Mohammed Abdu honored in a unique, grandeur style Winning second Guinness certificate; Turki Al-Sheikh surprises him with presence on stage    Saudi Stock Exchange Main Index Ends Trading Higher at 12,290 Points    Riyadh's Qualitative Events Enrich its Winter, Attract World Attention    GASTAT: Real estate prices rise by 0.9% in Q4 of 2021    22 Drivers from 11 Countries to Race for Glory at 2022 Diriyah E-Prix from January 28, 2022    SFDA: Fat is a Source of Energy and Its Abundance is Linked to Chronic Diseases    Reflections on celebration of Christmas    Royal Commission for AlUla to Hold Custodian of the Two Holy Mosques Endurance Cup 2022, Richard Mille AlUla Desert Polo    Saudi Arabia's Pavilion at Expo 2020 Dubai Organizes a Dance Theatrical Show for Children    Saudi Arabia rebuffs UN resolution on 'sexual orientation'    Kabir Khan eyes on joint Indian – Saudi film projects    Bollywood superstar Salman Khan to dazzle Riyadh Season on Dec. 10    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    Council of Senior Scholars: Muslim Brothers' Group Don't Represent Method of Islam, rather only Follows its Partisan Objectives, Violating our Graceful Religion    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    Pilgrims Perform Dhuhr and Asr Prayers in Arafat Holy Site    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

EU approves Moderna COVID-19 vaccine, paving the way for its rollout next week
Published in The Saudi Gazette on 06 - 01 - 2021

The European Union has authorized Moderna's Covid-19 vaccine, the second coronavirus vaccine to be approved for use in the EU.
The move finalizes the recommendation of the European Union drugs regulator, who earlier on Wednesday recommended granting the drug a conditional marketing authorization.
Emer Cooke, the European Medicines Agency (EMA) executive director, said on Wednesday that "this vaccine provides us with another tool to overcome the current emergency."
"It is a testament to the efforts and commitment of all involved that we have this second positive vaccine recommendation just short of a year since the pandemic was declared by WHO," she said.
The EU has secured the purchase of up to 160 million doses of the Moderna vaccine — enough to vaccinate 80 million people of its 448 million citizens — as part of a joint vaccine strategy aimed to ensure equitable access across the bloc.
Under that contract, the US biotech firm has promised to deliver all their doses between now and September 2021, the European Commission said.
Moderna said in a statement that the first deliveries of their vaccine "from Moderna's dedicated non-US supply chain are expected to begin next week."
Ursula von der Leyen, President of the European Commission celebrated Wednesday's outcome, saying that "we are providing more COVID-19 vaccines for Europeans. With the Moderna vaccine...we will have further 160 million doses. And more vaccines will come."
Noting that Europe has secured up to 2 billion doses of potential COVID-19 vaccines, von der Leyen added, "We'll have more than enough safe and effective vaccines for protecting all Europeans."
Stella Kyriakides, the EU's Commissioner for Health and Food Safety said that "we are all in this together and united," adding that that "our efforts will not stop until vaccines are available for everyone in the EU."
Kyriakides also said that member states will "have to ensure that the pace of vaccinations follows suit."
The 27-member bloc is already facing logistical challenges in rolling out the Pfizer/BioNTech vaccine, which the EU purchased 300 million doses of and which was authorized for use on Dec. 21 and rolled out just days later.
In France, as of Jan. 1, the number of people vaccinated stood at a paltry 516, according to data made available by the French health agency.
That rate seems to undermine the promise of French Prime Minister Jean Castex, who said that 1 million people would able to be vaccinated by the end of the month.
Jean Rottner, the head of France's "Great East" region, which has been badly impacted by the second wave, said that the slow vaccination rate is "a state scandal," and that he wanted territories to "take over" from the government.
"We are making fun of ourselves because today, being vaccinated has become more complicated than buying a car," Rottner said on public broadcaster France 2.
"We need to accelerate, we are at war," he said, "adding that "today, we need to vaccinate everywhere we can, with the means that are at our disposal."
The German government has also come under pressure from both politicians and scientific experts for not securing enough doses of the Pfizer/BioNTech vaccine to roll out its vaccination program.
Germany has immunized 316,962 people — around 0.4 percent of the country's population — according to Tuesday's data from the Robert Koch Institute, the national agency for disease control and prevention.
Among those vaccinated were around 131,885 residents of nursing homes and around 149,727 medical staff, according to data collected from Germany's federal states.
German health minister Jens Spahn rejected criticism of the delay in inoculations, saying in an interview with public broadcaster ARD on Tuesday that vaccination doses currently available in Germany are "exactly the order of magnitude I have been announcing for weeks."
At the same time, Spahn emphasized that efforts to procure more vaccine doses for Germany are underway, with authorities "very actively" supporting the construction of a new BioNTech production plant in Marburg.
Experts have warned that the biggest challenge for the EU will be the actual rollout of the vaccine, given that both the Pfizer/BioNTech and Moderna shot, which uses new mRNA technology, differs significantly from other more traditional vaccines in terms of storage.
Moderna's vaccine can be stored at temperatures of -20 Celsius (-4 Fahrenheit) for up to six months and at refrigerator temperatures of 2-8C (35-46F) for up to 30 days. It can also be kept at room temperature for up to 12 hours, and doesn't need to be diluted prior to use.
The Pfizer/BioNTech vaccine presents more complex logistical challenges, as it must be stored at around -70C (-94F) and lasts just five days in a refrigerator. Vials of the drug also need to be diluted for injection; once diluted, they must be used within six hours, or thrown out. — Courtesy CNN
Vaccine candidates such as Oxford/AstraZeneca's offering — which is already being distributed in the UK and which experts believe is likely to be approved by European regulators next — can be kept at normal refrigerator temperatures for at least six months, a benefit to those countries which are ill-equipped to handle the additional demands of cold-chain storage.
A strong cold-chain network is just one aspect when it comes to effectively distributing vaccines, however.
Other factors such as monitoring systems, community engagement and human resourcing are also all crucial to a successful rollout.

Clic here to read the story from its source.